FibroGen and Astellas Announce Initiation of Phase 3 Trial of FG-4592/ASP1517 for Treatment of Anemia of Chronic Kidney Disease

Download

• Small JPEG, 471x163, 16.7 KB
• Preview JPEG, 144x50, 4.5 KB
• Thumbnail JPEG, 72x25, 1.9 KB